Starpharma Holdings Ltd

PQ6

Company Profile

  • Business description

    Starpharma Holdings Ltd is an Australian biotechnology company focused on developing targeted oncology therapeutics, including radiopharmaceuticals, using its clinically validated DEP (Dendrimer Enhanced Product) drug delivery platform. Leveraging more than 20 years of dendrimer expertise, it is advancing novel, proprietary assets and strategic partnerships aimed at improving patient outcomes.

  • Contact

    4-6 Southampton Crescent
    Abbotsford
    MelbourneVIC3067
    AUS

    T: +61 385322700

    https://www.starpharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    Employees

    50

Stocks News & Analysis

stocks

Overvalued ASX share has overly ambitious profit target

We think the new profit target is aggressive and unlikely to be met.
stocks

7 undervalued US stocks that crushed earnings

Arista and GE Vernova remain among the cheapest Morningstar-covered stocks after strong earnings beats.
stocks

Undervalued ASX share hitting on all cylinders

Strong performance across all segments in latest earnings release.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,165.4039.10-0.42%
CAC 408,352.0016.91-0.20%
DAX 4026,598.64151.31-0.57%
Dow JONES (US)51,608.17739.38-1.41%
FTSE 10010,881.5521.01-0.19%
HKSE23,753.84116.240.49%
NASDAQ24,509.76626.52-2.49%
Nikkei 22559,662.021,480.33-2.42%
NZX 50 Index14,260.8542.92-0.30%
S&P 5007,416.59145.08-1.92%
S&P/ASX 2009,044.7037.50-0.41%
SSE Composite Index3,602.5731.78-0.87%

Market Movers